News

The 340B drug discount program is a Federal Public Health Service Program that allows qualified health centers and hospitals to buy drugs for less than half the cost

The new services include sample aliquoting, nucleic acid extraction and verification and PBMC (Peripheral Blood Mononuclear Cells) processing. With the new services, the company can provide a sample

Initially, DTMI will work with BMY on the clinical development of BMS-986202, an orally available lysophosphatidic acid 1 receptor antagonist under investigation to treat idiopathic pulmonary fibrosis. The

The new methodologies will assist scientists in pursuing disease and drug research, the companies said. The collaboration aims to develop a next-generation super exome, which incorporates sequence regions

TRU Legionella provides optimized detection of Legionella pneumophila serogroup 1 that is most commonly associated with Legionnaire’s disease. TRU Legionella allows the laboratories with a cost effective and

The FDA will evaluate the BLA for an indication of managing preoperative or bleeding patients who require replacement of multiple plasma coagulation factors, the company said. The BLA

The company has begun negotiations for the manufacturing and national distribution of this new product line. The negotiations will actively continue when the first prototypes are received by

iNO is available as Inomax (nitric oxide) for inhalation, that selectively relaxes the cells of the pulmonary vasculature, resulting in increased blood flow through the lungs and delivery

The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.